Opportunity Information: Apply for PAR 18 479
The NIH funding opportunity titled "Detecting and Preventing Suicide Behavior, Ideation and Self-Harm in Youth in Contact with the Juvenile Justice System (R01 - Clinical Trial Required)" supports rigorous, real-world research aimed at reducing suicide behavior, suicidal thoughts, and non-suicidal self-injury among youth who interact with the juvenile justice system. The core purpose is to fund studies that do more than just identify risk; applicants are expected to test combined approaches that both detect risk early and deliver interventions that can meaningfully prevent harm. Because the mechanism is an R01 and a clinical trial is required, the emphasis is on larger-scale effectiveness testing rather than early feasibility work, with an expectation that the study design will be strong enough to produce actionable evidence for practice.
A central feature of this opportunity is its focus on the many points where youth come into contact with juvenile justice processes, and how those touchpoints can be used to identify and reduce risk. The announcement highlights that opportunities for detection and prevention begin at very early stages such as police interactions and intake interviews, and continue across a wide range of settings including pre-trial detention, juvenile or family court activities, court disposition, and placement settings. Importantly, the FOA recognizes that youth may move between residential placements and community-based supervision or services, so research proposals can target single settings or multiple settings along that pathway, as long as the strategy is plausible and well-integrated into how juvenile justice services are typically delivered.
The FOA strongly encourages intervention strategies that fit the realities of day-to-day juvenile justice and affiliated service environments. That means interventions should be designed to work in typical service settings using staff, infrastructure, and resources that are usually available, rather than relying on highly specialized personnel or unusually intensive supports that would make it hard to replicate. The practical goal behind this is implementation readiness: if an intervention works under study conditions, it should have a realistic chance of being adopted broadly across diverse jurisdictions and program types. In other words, the research is expected to be relevant to scale-up, future uptake, and sustained use, not just short-term success in a highly controlled research setting.
This R01 opportunity was published alongside a companion R34 funding announcement intended for pilot studies that help teams prepare for the larger, more definitive trials envisioned here. In practice, that parallel structure signals a pipeline: the R34 supports preliminary work like refining procedures, testing feasibility, and establishing initial signals, while this R01 is meant for more mature projects that are ready to formally test effectiveness in the field. Applicants considering the R01 are therefore implicitly expected to have a strong foundation for their proposed clinical trial, including clear protocols and a plan for delivering and evaluating the combined detection and intervention approach.
In terms of who can apply, eligibility is broad and includes many types of U.S.-based entities that could realistically conduct justice-related health research. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public and private institutions of higher education; federally recognized tribal governments and other tribal organizations; public housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations other than small businesses; and small businesses. The FOA also explicitly calls out additional eligible categories such as faith-based or community-based organizations, Hispanic-serving institutions, Historically Black Colleges and Universities, Tribally Controlled Colleges and Universities, Alaska Native and Native Hawaiian serving institutions, and AANAPISIS institutions, among others, reflecting an interest in engaging organizations that serve diverse and often disproportionately impacted communities.
At the same time, there are clear restrictions related to foreign involvement. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply, and non-domestic components of U.S. organizations are also not eligible. In addition, foreign components as defined by NIH policy are not allowed, meaning the funded work must be conducted without foreign components under the NIH Grants Policy framework. These boundaries keep the focus on U.S.-based juvenile justice systems and the service contexts in which U.S. youth receive screening, supervision, detention, court involvement, and related services.
The source details characterize this as a discretionary NIH grant (CFDA 93.242) with a listed award ceiling of $500,000, and the opportunity number is PAR-18-479. The original closing date shown is January 7, 2021, and the FOA was created on December 7, 2017. Overall, the opportunity is geared toward producing solid evidence on what actually works to identify risk and prevent suicide-related outcomes and self-harm among justice-involved youth, with an intentional push toward approaches that can be implemented broadly in routine juvenile justice and community service settings.Apply for PAR 18 479
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Detecting and Preventing Suicide Behavior, Ideation and Self-Harm in Youth in Contact with the Juvenile Justice System (R01- Clinical Trial Required)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242.
- This funding opportunity was created on 2017-12-07.
- Applicants must submit their applications by 2021-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Announcement for Program Funding for NRCS' Conservation Innovation Grants (CIG) for Federal fiscal year (FY) 2018
Previous opportunity: Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 18 479
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 18 479) also looked into and applied for these:
| Funding Opportunity |
|---|
| NIDCR Dental Specialty and PhD Program (DSPP)(K12-Clinical Trials Not Allowed) Apply for RFA DE 18 012 Funding Number: RFA DE 18 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD Early Career Research(ECR) Award (R21 - Clinical Trials Optional) Apply for PAR 18 487 Funding Number: PAR 18 487 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Exosomes: From Biogenesis and Secretion to the Early Pathogenesis of Alzheimer's Disease (R01 - Clinical Trial Not Allowed) Apply for RFA AG 18 027 Funding Number: RFA AG 18 027 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Deciphering the Molecular Landscape of Lung Aging in Humans (U01 - Clinical Trial Not Allowed) Apply for RFA HL 19 012 Funding Number: RFA HL 19 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Sleep disorders and circadian clock disruption in Alzheimers disease and other dementias of aging (R01 Clinical Trial Not Allowed) Apply for PAR 18 497 Funding Number: PAR 18 497 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| From Association to Function in the Alzheimers Disease Post-Genomics Era (R01 - Clinical Trial Not Allowed) Apply for RFA AG 18 026 Funding Number: RFA AG 18 026 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Interdisciplinary Research to Understand the Complex Biology of Resilience to Alzheimers Disease Risk (R01 - Clinical Trial Not Allowed) Apply for RFA AG 18 029 Funding Number: RFA AG 18 029 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00-Clinical Trial Required) Apply for PAR 18 432 Funding Number: PAR 18 432 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pragmatic Trials of Managing Multimorbidity in Alzheimers Disease (R01 Clinical Trial Required) Apply for RFA AG 18 028 Funding Number: RFA AG 18 028 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIBIB Exploratory/Developmental Research Grant Program (R21) (Clinical Trial Optional) Apply for PAR 18 433 Funding Number: PAR 18 433 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Human Subjects Mechanistic and Minimal Risk Studies (R21 Clinical Trial Optional) Apply for PA 18 500 Funding Number: PA 18 500 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Discovery and Biological Signatures of Diet Derived Microbial Metabolites (R01 Clinical Trial Optional) Apply for RFA AT 18 003 Funding Number: RFA AT 18 003 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required) Apply for PAR 18 513 Funding Number: PAR 18 513 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Health-professional Education Partnership Initiative (HEPI) (R25 Clinical Trial Not Allowed) Apply for RFA TW 17 001 Funding Number: RFA TW 17 001 Agency: National Institutes of Health Category: Health Funding Amount: $600,000 |
| Effects of In Utero Alcohol Exposure on Adult Health and Disease (R01 - Clinical Trial Optional) Apply for PA 18 507 Funding Number: PA 18 507 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Consequences of amyloid protein polymorphisms in Alzheimer's disease (R01 - Clinical Trial Not Allowed) Apply for RFA AG 18 025 Funding Number: RFA AG 18 025 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| NEI Collaborative Clinical Vision Project: Resource Center Grant (UG1- Clinical Trial Required) Apply for PAR 18 522 Funding Number: PAR 18 522 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Effects of In Utero Alcohol Exposure on Adult Health and Disease (R21 - Clinical Trial Optional) Apply for PA 18 508 Funding Number: PA 18 508 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| CREATE Bio Development Track: Preclinical and Early-Phase Clinical Development for Biologics (U44 SBIR- Clinical Trial Optional) Apply for PAR 18 543 Funding Number: PAR 18 543 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01) Apply for PAR 18 534 Funding Number: PAR 18 534 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 479", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
